Pharmacokinetic Profile of Inhaled Liposomal Amphotericin B in Lung Transplant Recipients - Ambisome Study
Status:
Completed
Trial end date:
2007-12-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to determine the steady state concentrations of inhaled
liposomal amphotericin B (Ambisome®) in lung transplant recipients via aerosolized
nebulization.